sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Medical Devices

Remote Patient Monitoring MarketSize, Share & Industry Analysis, 2026-2034By Product TypeBy ComponentBy ApplicationBy End UserBy Connectivity TechnologyBy WearabilityBy Deployment ModeBy Care ModelBy Patient Age GroupBy Sales Channel

Full title & scope — all 10 axes with their segments

Remote Patient Monitoring Market Size, Share & Industry Analysis, By Product Type (Vital Signs Monitors, Glucose Monitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Multi-parameter Monitors, Fetal and Neonatal Monitors, Neurological Monitors, Weight and Body Composition Scales), By Component (Devices, Software and Platforms, Services), By Application (Cardiovascular Diseases, Diabetes, Respiratory Diseases, Neurological Disorders, Cancer, Maternal and Fetal Health, Post-acute and Post-operative Care, Other Chronic Conditions), By End User (Home Care Settings, Hospitals and Clinics, Ambulatory Care Centers, Assisted Living and Long-term Care Facilities, Rehabilitation Centers, Payers and Care Management Organizations), By Connectivity Technology (Bluetooth, Wi-Fi, Cellular, Wired and Hub-based, Other Wireless Protocols), By Wearability (Wearable, Handheld, Tabletop and Bedside, Implantable and Ingestible), By Deployment Mode (Cloud-based, On-premise, Hybrid), By Care Model (Real-time Monitoring, Store-and-forward Monitoring, Hospital-at-home, Chronic Care Management, Principal Care Management), By Patient Age Group (Geriatric, Adult, Pediatric, Neonatal), By Sales Channel (Direct to Providers, Distributors and Wholesalers, Retail and Pharmacies, Online and E-commerce, Payer-sponsored Programs), and Regional Forecast, 2026-2034

Last Updated: Oct 28, 2026Format: PDFReport ID: CDI-248812
Segmentation

Segment definitions and share of revenue by product, animal, end user and region.

Segmented by
Product Type
Component
Application
End User
Connectivity Technology
Wearability
Deployment Mode
Care Model
Patient Age Group
Sales Channel
Structure

Segmentation Analysis

10 axes

By Product Type

8
  • 01Vital Signs Monitors
  • 02Glucose Monitoring Devices
  • 03Cardiac Monitoring Devices
  • 04Respiratory Monitoring Devices
  • 05Multi-parameter Monitors
  • 06Fetal and Neonatal Monitors
  • 07Neurological Monitors
  • 08Weight and Body Composition Scales

By Component

3
  • 01Devices
  • 02Software and Platforms
  • 03Services

By Application

8
  • 01Cardiovascular Diseases
  • 02Diabetes
  • 03Respiratory Diseases
  • 04Neurological Disorders
  • 05Cancer
  • 06Maternal and Fetal Health
  • 07Post-acute and Post-operative Care
  • 08Other Chronic Conditions

By End User

6
  • 01Home Care Settings
  • 02Hospitals and Clinics
  • 03Ambulatory Care Centers
  • 04Assisted Living and Long-term Care Facilities
  • 05Rehabilitation Centers
  • 06Payers and Care Management Organizations

By Connectivity Technology

5
  • 01Bluetooth
  • 02Wi-Fi
  • 03Cellular
  • 04Wired and Hub-based
  • 05Other Wireless Protocols

By Wearability

4
  • 01Wearable
  • 02Handheld
  • 03Tabletop and Bedside
  • 04Implantable and Ingestible

By Deployment Mode

3
  • 01Cloud-based
  • 02On-premise
  • 03Hybrid

By Care Model

5
  • 01Real-time Monitoring
  • 02Store-and-forward Monitoring
  • 03Hospital-at-home
  • 04Chronic Care Management
  • 05Principal Care Management

By Patient Age Group

4
  • 01Geriatric
  • 02Adult
  • 03Pediatric
  • 04Neonatal

By Sales Channel

5
  • 01Direct to Providers
  • 02Distributors and Wholesalers
  • 03Retail and Pharmacies
  • 04Online and E-commerce
  • 05Payer-sponsored Programs

Segment categories shown for scope reference. See the Summary tab for revenue share by Product Type. Full segment-by-segment detail across every axis is available in the sample and full report.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Remote Patient Monitoring Market projected to reach?

USD 169 USD Billion by 2034, CAGR 12.47%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 41% of global revenue through 2034.

05Which segment leads the market?

Cardiac Monitoring Devices is the largest line by product type, at 24% of revenue in 2025.

06Who are the key companies profiled?

Koninklijke Philips N.V., Medtronic plc, GE HealthCare Technologies Inc., Masimo Corporation, Abbott Laboratories, Dexcom, Inc., OMRON Healthcare, Inc., iRhythm Technologies, Inc., Boston Scientific Corporation, Siemens Healthineers AG, Baxter International Inc., BioTelemetry, Inc., Biotricity Inc., Teladoc Health, Inc., Vivify Health, Inc., Resideo Technologies, Inc., VitalConnect, Inc., VivaLNK, Inc., Oracle Corporation, Health Recovery Solutions, Inc., Best Buy Health, Inc., Cadence (Cadence Health), Inc., BioIntelliSense, Inc., Withings SA, Tunstall Healthcare Group Ltd., Medtronic Care Management Services, A&D Company, Limited, Insulet Corporation, ResMed Inc., CareClix (Dignity Health Global Education). Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.